Logo Image
|Poll|November 19, 2020

Optometry Times Journal

  • November digital edition 2020
  • Volume 12
  • Issue 11

Quiz: Treatments for presbyopia coming soon

quick quiz

This quiz accompanies THIS article from our November issue

1. What is the prevalence of presbyopia in the U.S.?

a. 5,000,000
b. 10,500,000
c. 50,000,000
d. 110,000,000

2. Miotics have few side effects.

a. True
b. False

3. Which of these devices uses pinhole optics (PHO)?

Revision Raindrop
b. Karama Inlay
c. FOV Tears
d. Allergan Presbysol
e. B and D

4. Which of these is not a pharmaco-refractive product?

a. Oraisis CSF-1
b. Presbyopia Therapies PRX-100
c. Allergan AGN
d. Eyenovia Micro-dose
e. All are pharmaco-refractive

5. What is the most common ingredient in current pharmaceutical drops for presbyopia being tested?

a. Dexamethasone
b. Pilocarpine
c. Bromfenac
d. Tropicamide
e. None of the above

6. Which of these is a device?

a. Oraisis CSF-1
b. Presbyopia Therapies PRX-100
c. Allergan AGN
d. Eyenovia Micro-dose
e. FOV Tears

Which is an active ingredient in PRX-100?

a. Pilocarpine
b. Tropicamide
c. Oxymetazoline
d. Polyethylene glycol
e. Diclofenac

Click here to see the correct answers

This quiz accompanies THIS article from our November issue

Articles in this issue

almost 6 years ago

Quiz Answers: Treatments for presbyopia coming soon

almost 6 years ago

When to lease and when to own office space

almost 6 years ago

Vision rehabilitation of patients with stroke

almost 6 years ago

Treatments for presbyopia coming soon

almost 6 years ago

How diabetes affects COVID-19

almost 6 years ago

Novel uses of technology for systemic disease

almost 6 years ago

Know the pros and cons of outsourcing billing

almost 6 years ago

5 communication strategies for dry eye patients

almost 6 years ago

2 factors that increase risk of microbial keratitis in contact lens wearers

almost 6 years ago

Association found between laminar thinning and poor cognitive function

Related to this article

View more